136 related articles for article (PubMed ID: 31502352)
1. A six-CpG-based methylation markers for the diagnosis of ovarian cancer in blood.
Wang L; Ni S; Du Z; Li X
J Cell Biochem; 2020 Feb; 121(2):1409-1419. PubMed ID: 31502352
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation signatures and coagulation factors in the peripheral blood leucocytes of epithelial ovarian cancer.
Li L; Zheng H; Huang Y; Huang C; Zhang S; Tian J; Li P; Sood AK; Zhang W; Chen K
Carcinogenesis; 2017 Aug; 38(8):797-805. PubMed ID: 28637314
[TBL] [Abstract][Full Text] [Related]
3. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract][Full Text] [Related]
4. Identification of hub methylated-CpG sites and associated genes in oral squamous cell carcinoma.
Dai Y; Lv Q; Qi T; Qu J; Ni H; Liao Y; Liu P; Qu Q
Cancer Med; 2020 May; 9(9):3174-3187. PubMed ID: 32155325
[TBL] [Abstract][Full Text] [Related]
5. Identification potential epigenetic biomarkers of a human immunodeficiency virus/tuberculosis co-infection based on weighted gene co-expression network analysis.
Xu S; Yuan H; Li L; Bai F; Yang K; Zhao L
Microbiol Immunol; 2021 Oct; 65(10):422-431. PubMed ID: 34125446
[TBL] [Abstract][Full Text] [Related]
6. Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer.
Sung HY; Yang SD; Ju W; Ahn JH
Exp Mol Med; 2017 May; 49(5):e335. PubMed ID: 28524180
[TBL] [Abstract][Full Text] [Related]
7. 3 CpG Methylation Biomarkers for the Diagnosis of Polycystic Ovary Syndrome (PCOS) in Blood Samples.
Xie L; Jiang X; Chen Y; Huang C; Chen Y; Liu G; Sun W; Zeng L; Lu R
Comb Chem High Throughput Screen; 2022; 25(8):1304-1313. PubMed ID: 34080962
[TBL] [Abstract][Full Text] [Related]
8. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
9. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
[TBL] [Abstract][Full Text] [Related]
10. RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.
Häfner N; Steinbach D; Jansen L; Diebolder H; Dürst M; Runnebaum IB
Int J Cancer; 2016 Jan; 138(1):217-28. PubMed ID: 26175272
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
12. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
[TBL] [Abstract][Full Text] [Related]
13. Genome-scale screen for DNA methylation-based detection markers for ovarian cancer.
Campan M; Moffitt M; Houshdaran S; Shen H; Widschwendter M; Daxenbichler G; Long T; Marth C; Laird-Offringa IA; Press MF; Dubeau L; Siegmund KD; Wu AH; Groshen S; Chandavarkar U; Roman LD; Berchuck A; Pearce CL; Laird PW
PLoS One; 2011; 6(12):e28141. PubMed ID: 22163280
[TBL] [Abstract][Full Text] [Related]
14. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation subtypes for ovarian cancer prognosis.
Yin L; Zhang N; Yang Q
FEBS Open Bio; 2021 Mar; 11(3):851-865. PubMed ID: 33278864
[TBL] [Abstract][Full Text] [Related]
16. Identification of inflammation-related DNA methylation biomarkers in periodontitis patients based on weighted co-expression analysis.
Wang P; Wang B; Zhang Z; Wang Z
Aging (Albany NY); 2021 Aug; 13(15):19678-19695. PubMed ID: 34347624
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential blood biomarkers for Parkinson's disease by gene expression and DNA methylation data integration analysis.
Wang C; Chen L; Yang Y; Zhang M; Wong G
Clin Epigenetics; 2019 Feb; 11(1):24. PubMed ID: 30744671
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers.
Liu X; Peng Y; Wang J
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32412047
[TBL] [Abstract][Full Text] [Related]
19. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
20. A seven-gene CpG-island methylation panel predicts breast cancer progression.
Li Y; Melnikov AA; Levenson V; Guerra E; Simeone P; Alberti S; Deng Y
BMC Cancer; 2015 May; 15():417. PubMed ID: 25986046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
